As previously reported, Northland upgraded Astera Labs (ALAB) to Outperform from Market Perform with a $120 price target after shares in the company fell 28% on Monday as Chinese artificial-intelligence startup DeepSeek’s low-cost approach reignited concerns that big U.S. companies have poured too much money into developing AI. However, the firm does not expect Amazon (AMZN), Alphabet (GOOG) (GOOGL), Meta (META) and Microsoft (MSFT) to cut capital expenditure forecasts when they report earnings in the comings days, which it believes should act as a catalyst for Astera, the analyst tells investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Astera Labs upgraded to Outperform from Market Perform at Northland
- Unusually active option classes on open January 21st
- Astera Labs downgraded to Equal Weight from Overweight at Morgan Stanley
- Astera Labs price target raised to $135 from $87 at Barclays
- Astera Labs price target raised to $150 from $100 at Stifel